T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report released on Sunday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 2.5 %

Shares of T2 Biosystems stock opened at $0.41 on Friday. T2 Biosystems has a fifty-two week low of $0.31 and a fifty-two week high of $6.95. The company has a fifty day moving average of $0.53 and a 200 day moving average of $2.46.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in T2 Biosystems stock. Armistice Capital LLC purchased a new stake in T2 Biosystems, Inc. (NASDAQ:TTOO) during the second quarter, according to its most recent filing with the SEC. The fund purchased 1,658,000 shares of the medical equipment provider’s stock, valued at approximately $8,854,000. Armistice Capital LLC owned about 9.49% of T2 Biosystems as of its most recent filing with the SEC. Institutional investors own 23.18% of the company’s stock.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.